EMEA's CHMP recommends approval of Merck's ELONVA

20. November 2009 08:52

Merck & Co., Inc. today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval of ELONVA® (corifollitropin alfa injection) as a treatment in controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program. [More]

6bf91f5b-3469-4016-af69-65b302f579e3|0|.0

Posted in: Drug Trial News | Women's Health News

Tags: Antibody, Endometriosis, Fertility, Gonadotropin, Headache, Infertility, IVF, Nausea, Pregnancy, Sperm

Soligenix receives $9.4M NIAID grant to develop technology for advancing rapidly acting vaccines

20. November 2009 07:45

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has formed a consortium to develop thermostable technology to advance RiVax(TM) and other rapidly acting vaccines. Soligenix received a $9.4 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to support this work. [More]

25d5bf3a-1a13-4ddf-befb-b2fa1aaa7721|0|.0

Posted in: Device / Technology News | Pharmaceutical News

Tags: Allergy, Anthrax, Beclomethasone, Biotechnology, Cancer, Cell, Corticosteroid, Drug Delivery, Endometriosis, Prostate Cancer, Vaccine

Third quarter 2009 financial results announced by Soligenix

13. November 2009 07:36

Soligenix, Inc., (Soligenix or the Company) (OTC Bulletin Board: SNGX), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today its financial results for the third quarter of 2009. [More]

0b7889c9-dd34-4401-ba2f-1ebfb694c8ec|0|.0

Posted in: Business / Finance

Tags: Allergy, Beclomethasone, Biotechnology, Cancer, Cell, Corticosteroid, Drug Delivery, Endometriosis, Prostate Cancer, Vaccine

Ipsen receives marketing authorization in France for its 6-month sustained-release formulation of Decapeptyl

13. November 2009 01:39

Ipsen, an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities (Agence Française de Sécurité Sanitaire des Produits de Santé, AFSSAPS) have today granted the marketing authorization to the 6-month sustained-release formulation of Decapeptyl® (triptorelin embonate 22.5 mg) for the treatment of locally advanced and metastatic prostate cancer. [More]

0c512257-aa74-4a4f-8fd5-eab3f9106186|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Cancer, Endocrinology, Endometriosis, Gonadotropin, Hypothalamus, Neurology, Oncology, Prostate Cancer, Puberty, Testosterone

Pfizer and BMP Sunstone team up to promote Depo-Provera, a product for treating endometriosis

11. November 2009 01:12

Pfizer China and BMP Sunstone Corporation today announced a strategic partnership to exclusively import, distribute and promote Depo-Provera (Medroxy-progesterone Acetate), a Pfizer product used to treat endometriosis, in China. Endometriosis is a medical condition in women of childbearing age that can cause significant pain. [More]

c657f145-161c-4932-ba14-d0658c04aa7c|0|.0

Posted in: Medical Condition News | Women's Health News

Tags: Depo-Provera, Endometriosis, Pediatrics, Pfizer, Progesterone

Researchers to study how microbial imbalances impact breast cancer

29. October 2009 01:32

The human body contains billions of microorganisms, and microbial cells found in the human gut are estimated to outnumber human cells by ten-to-one in healthy adults. However, little is known about the ways in which these minute life forms influence health and disease. [More]

0ed829f6-d8b3-4ddc-85c0-a1c738d6a436|0|.0

Posted in: Medical Science News | Women's Health News

Tags: Breast Cancer, Cancer, Cirrhosis, Crohn's Disease, DNA, Endometriosis, Estrogen, Hospital, Inflammatory Bowel Disease, Metabolism, Nursing, Nutrition, Osteoporosis, Ovarian Cancer

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

28. October 2009 12:08

The human body contains billions of microorganisms, and microbial cells found in the human gut are estimated to outnumber human cells by ten-to-one in healthy adults. However, little is known about the ways in which these minute life forms influence health and disease. [More]

310107c4-4caf-4798-a48f-5840a6298155|0|.0

Posted in: Medical Condition News | Disease/Infection News

Tags: Breast Cancer, Cancer, Cirrhosis, Crohn's Disease, DNA, Endometriosis, Estrogen, Hospital, Inflammatory Bowel Disease, Metabolism, Nursing, Nutrition, Osteoporosis, Ovarian Cancer

Datamonitor's report on the global hormonal contraceptive market

28. October 2009 06:45

Research and Markets (http://www.researchandmarkets.com/research/f10fda/commercial_insight) has announced the addition of the "Commercial Insight: Hormonal Contraceptives - Look Beyond Oral Contraception for a Competitive Edge" report to their offering. [More]

9ace2116-7fd1-440e-abdf-aefc7d94a2e8|0|.0

Posted in: Women's Health News | Pharmaceutical News

Tags: Acne, Birth Control, Contraception, Endometriosis, Estrogen, Yasmin

Report on immunotherapies and vaccines for nontraditional indications

27. October 2009 07:23

Reportlinker Adds Immunotherapies and Vaccines for Nontraditional Indications [More]

af658754-fc7c-4c13-ace7-e78ad0b60768|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Alzheimer's Disease, Angina, Angiotensin, Ankylosing Spondylitis, Antibody, Anti-Inflammatory, Arthritis, Atherosclerosis, Avastin, Back Pain, beta Amyloid, Bevacizumab, Biotechnology, Bone, Breast Cancer, Cancer, Cardiovascular Disease, Cell, Cholesterol, Cocaine Addiction, Colorectal Cancer, Denosumab, Diabetes, Diabetic Macular Edema, Diabetic Retinopathy, Dyslipidemia, Eculizumab, Edema, Endometriosis, Glioblastoma, Hematology, Immunotherapy, Lipids, Lung Cancer, Macular Degeneration, Metabolism, Monoclonal Antibody, Neurology, Neuropathy, Nicotine, Nicotine Addiction, Non-Small Cell Lung Cancer, Ophthalmology, Osteoporosis, Parkinson's Disease, Pfizer, Polio, Ranibizumab, Rheumatoid Arthritis, Small Cell Lung Cancer, Smoking, Smoking Cessation, Stroke, Thrombosis, Transplant, Type 2 Diabetes, Uveitis, Vaccine, VEGF

Soligenix commences enrollment in its Phase 3 Orbec clinical trial for acute GI GVHD

15. October 2009 07:52

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD). [More]

e238801d-f2fd-4cb0-9da5-261aee505813|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Anorexia, Asthma, Beclomethasone, Biotechnology, Bone, Bone Marrow, Cancer, Cell, Corticosteroid, Diarrhea, Drug Delivery, Endometriosis, Nausea, New Drug Application, Oncology, Prostate Cancer, Rhinitis, Stem Cell, Transplant, Vaccine, Vomiting

Debiopharm Group and Ipsen complete European decentralised registration of Decapeptyl

13. October 2009 02:09

Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group, announced that the 6-month sustained-release formulation of Decapeptyl®1 (triptorelin embonate2 22.5 mg) successfully completed its European decentralised registration procedure involving nine countries: Germany (reference member state), France, Austria, Finland, Norway, Belgium, Denmark, Spain and The Netherlands. [More]

34a6f021-439b-4aca-830f-dfca0e2e6c0a|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Cancer, Drug Delivery, Endocrinology, Endometriosis, Gonadotropin, Hypothalamus, Neurology, Oncology, Prostate Cancer, Puberty, Testosterone

Frost & Sullivan: EU contract research organization market estimated to reach $13.52 billion in 2015

12. October 2009 08:20

Although cost efficiency is a major factor motivating pharmaceutical and biotechnology firms to outsource research, there is an increased emphasis on expertise and capabilities with the focus being on quality management. [More]

fa3af2d2-9697-406d-b4c8-f674a4b1bb76|0|.0

Posted in: Device / Technology News | Pharmaceutical News

Tags: Biotechnology, Endometriosis, Evolution, Incontinence, Investment, Osteoarthritis, Urinary Incontinence

Neurocrine Biosciences enters into an amendment to its facility lease agreement

5. October 2009 07:01

Neurocrine Biosciences, Inc. announced today that the Company has entered into an amendment to its facility lease agreement. The amendment eliminates approximately 70,000 square feet of leased space. [More]

4ea710f3-cf47-4051-b4cb-d7dea3228213|0|.0

Posted in: Business / Finance

Tags: Anxiety, Benign Prostatic Hyperplasia, Depression, Diabetes, Endometriosis, Irritable Bowel Syndrome

Repros Therapeutics receives further clarification on the Full Clinical Hold status of Proellex

29. September 2009 07:16

Repros Therapeutics today announced that the Company has received further clarification from the Food and Drug Administration (FDA) on the Full Clinical Hold status of Proellex. [More]

85f4c8ae-4d8a-47b6-ad42-00dfde7daf9c|0|.0

Posted in: Pharmaceutical News

Tags: Endometriosis, Investment, Oncology

DOR Biopharma to raise $3.85 million from institutional investors

25. September 2009 09:15

DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing. [More]

c95ea01c-32d1-421d-8b69-1fe5871dffdd|0|.0

Posted in: Business / Finance

Tags: Beclomethasone, Biotechnology, Cancer, Cell, Corticosteroid, Drug Delivery, Endometriosis, Prostate Cancer, Vaccine

Free!

Recent Comments

Twitter

Information

Endometriosis News and Research

EMEA's CHMP recommends approval of Merck's ELONVA

Soligenix receives $9.4M NIAID grant to develop technology for advancing rapidly acting vaccines

Third quarter 2009 financial results announced by Soligenix

Ipsen receives marketing authorization in France for its 6-month sustained-release formulation of Decapeptyl

Pfizer and BMP Sunstone team up to promote Depo-Provera, a product for treating endometriosis

Researchers to study how microbial imbalances impact breast cancer

U.S. Department of Defense funds Rush University Medical Center for gastrointestinal microorganism research

Datamonitor's report on the global hormonal contraceptive market

Report on immunotherapies and vaccines for nontraditional indications

Soligenix commences enrollment in its Phase 3 Orbec clinical trial for acute GI GVHD

Debiopharm Group and Ipsen complete European decentralised registration of Decapeptyl

Frost & Sullivan: EU contract research organization market estimated to reach $13.52 billion in 2015

Neurocrine Biosciences enters into an amendment to its facility lease agreement

Repros Therapeutics receives further clarification on the Full Clinical Hold status of Proellex

DOR Biopharma to raise $3.85 million from institutional investors

Recent Articles

Free!

Recent Comments

Twitter

Information

Endometriosis News and Research

Medical News Cloud

Recent Articles